Company description

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), an innovation focused global discovery, development and manufacturing organization provides integrated services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemicals industries across the world. Syngene’s clientele include market leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Zoetis, Merck KGaA and Herbalife. Its innovative culture is driven by a strong team of over 3500 scientists working with clients around the world to improve R&D productivity, while reducing development time and cost. For more details, visit www.syngeneintl.com .

Quick facts

Sales markets Western Europe, Eastern Europe, Middle East, Asia, Australia, North America, Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More

Upcoming events

12 dec 2018

CPhI & PMEC India 2018

12-14 December 2018 India Expo Centre, Greater Noida, Delhi NCR Visit us at stand 17.B13 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 3C100 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 643 See our Exhibitor Profile   See full Exhibitor List
18 apr 2018

CPhI Japan 2018

18 - 20 April 2018 Tokyo, Japan We were at stand L-24 See our Exhibitor Profile   See full Exhibitor List

News about Syngene International Ltd.

Syngene International Expands Collaboration with Baxter

12 Sep 2018

Syngene International Expands Collaboration with Baxter

Syngene International Ltd., a leading global Contract Research Organization, announced the expansion of the scope of its R&D collaboration with Baxter Healthcare Corporation, a global healthcare company. As part of the expansion, Syngene will set up additional infrastructure at the dedicated Baxter Global Research Center (BGRC) as well as increase the size of its scientific team working on Baxter projects. The duration of the agreement has also been extended until 2024.

Read more

9 Oct 2017

Syngene International Announces Broadening of Research Collaboration with Amgen Inc.

With the expansion, the floor space of Syngene Amgen Research & Development Center will double to 50,000 sq. ft. A team of up to 185 multi-disciplinary Syngene scientists will work in the areas of medicinal and process chemistry, biologics, bioprocess development, drug metabolism, pharmacokinetics, bioanalytical research and pharmaceutical development.

Read more
Syngene International Ltd.

Contact information




View all contact information